Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | YARS1 | P54577 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 3/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15661797 | 1.00 | FOLH1 (0.50) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL15235867 | 0.91 | FOLH1 (0.48) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL10703073 | 0.89 | FOLH1 (0.46) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL31744459 | 0.86 | KMT2A (0.42) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL2728052 | 0.86 | KMT2A (0.42) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL11039517 | 0.85 | FOLH1 (0.51) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL14015971 | 0.83 | MTOR (0.52) | NAALAD2SRCKMT2ALMNAALDH1A1 | |
| SCHEMBL30368057 | 0.80 | FOLH1 (0.44) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL31402508 | 0.79 | FOLH1 (0.49) | FOLH1NAALAD2SRCKMT2AATM | |
| SCHEMBL5427932 | 0.78 | FOLH1 (0.55) | FOLH1NAALAD2SRCKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110206650-A1 | Probiotic Formulations | BRACCO IMAGING S.P.A. (IT) | 2011-08-25 | — | — | US | claimed |
| EP-0145506-B1 | ELIMINATION OF DEFECTS IN CYSTEINE-SENSITIZED EMULSIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-03-02 | — | — | EP | claimed |
| CN-122055172-A | Chimeric radiopharmaceuticals targeting the proton-sensitive receptor GPR4 | 安菲利克斯股份公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260125407-A1 | PROCESS FOR THE PREPARATION OF POLYAMINOCARBOXYLIC ACIDS AND CHELATE COMPOUNDS THEREOF | VALAGRO S.P.A. (IT) | 2026-05-07 | — | — | US | disclosed |
| US-12534488-B2 | Process for the preparation of polyaminocarboxylic acids and chelate compounds thereof | VALAGRO S.P.A. (IT) | 2026-01-27 | — | — | US | disclosed |
| US-20250382259-A1 | METHOD FOR PREPARING CHELATABLE EDDHA | RAM TECHNOLOGY CO., LTD. (KR) | 2025-12-18 | — | — | US | disclosed |
| WO-2025242909-A1 | CD30-targeting antibody-radioligand conjugates and their therapeutic use | PAUL SCHERRER INSTITUT (CH) | 2025-11-27 | — | — | WO | disclosed |
| US-20250277247-A1 | NUCLEIC ACID AMPLIFICATIONS | IONIAN TECHNOLOGIES, LLC | 2025-09-04 | — | — | US | disclosed |
| EP-4610269-A1 | UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE | 3B Pharmaceuticals GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |
| EP-4455159-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS WITH BIO-DISTRIBUTION MODIFIER | 3B Pharmaceuticals GmbH (DE) | 2024-10-30 | — | — | EP | disclosed |
| EP-4069673-B1 | PROCESS FOR THE PREPARATION OF POLYAMINOCARBOXYLIC ACIDS AND CHELATE COMPOUNDS THEREOF | VALAGRO SPA (IT) | 2024-05-22 | — | — | EP | disclosed |
| US-20200131096-A1 | Biofertilizer Composition and Method of Manufacture | SUSTAINABLE COMMUNITY DEV LLC (US) | 2020-04-30 | — | — | US | disclosed |
| US-9980479-B2 | Method of reducing nematode damage | SYNGENTA CROP PROTECTION, LLC (US) | 2018-05-29 | — | — | US | disclosed |
| EP-1765079-B1 | METHODS OF REDUCING NEMATODE DAMAGE | SYNGENTA PARTICIPATIONS AG (CH) | 2017-11-29 | — | — | EP | disclosed |
| US-20130231299-A1 | METHODS FOR REDUCING NEMATODE DAMAGE | SYNGENTA CROP PROTECTION LLC (US) | 2013-09-05 | — | — | US | disclosed |
| US-20110206650-A1 | Probiotic Formulations | BRACCO IMAGING S.P.A. (IT) | 2011-08-25 | — | — | US | disclosed |
| EP-0334630-B1 | Iron chelate composition | PHOSYN PLC (GB) | 1993-11-18 | — | — | EP | disclosed |
| US-5152820-A | Increasing iron concentration of soils | PHOSYN PLC. (GB) | 1992-10-06 | — | — | US | disclosed |
| EP-0334630-A1 | Iron chelate composition | PHOSYN PLC (GB) | 1989-09-27 | — | — | EP | disclosed |
| EP-0145506-B1 | ELIMINATION OF DEFECTS IN CYSTEINE-SENSITIZED EMULSIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125407-A1 | PROCESS FOR THE PREPARATION OF POLYAMINOCARBOXYLIC ACIDS AND CHELATE COMPOUNDS THEREOF | PAH, HAO2, AGXT | FOLH1 719/4885NAALAD2 1748/4885SRC 2902/4885 |
| US-12534488-B2 | Process for the preparation of polyaminocarboxylic acids and chelate compounds thereof | PAH, GRHPR, AGXT | FOLH1 597/4885NAALAD2 1774/4885SRC 3177/4885 |
| US-20250382259-A1 | METHOD FOR PREPARING CHELATABLE EDDHA | EDNRA, QDPR, DOHH | FOLH1 17/4885NAALAD2 195/4885SRC 4829/4885 |
| US-20130231299-A1 | METHODS FOR REDUCING NEMATODE DAMAGE | PCNA, CAT, GMNN | FOLH1 1008/4885NAALAD2 213/4885SRC 4479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.